ConvergInce Holdings
2
31M
1
0.50
- Stages of investment
- Areas of investment
Summary
The main department of described Corporate Investor is located in the London. The company was established in Europe in United Kingdom.
The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the ConvergInce Holdings, startups are often financed by Oxford Capital Partners, Capricorn Venture Partners, Morningside Group. The meaningful sponsors for the fund in investment in the same round are Sofinnova Partners, Oxford Capital Partners, Capricorn Venture Partners. In the next rounds fund is usually obtained by Tennenbaum Capital Partners, Swire Pacific, Sofinnova Partners.
Among the various public portfolio startups of the fund, we may underline Green Biologics For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom. Moreover, a startup needs to be at the age of 11-15 years to get the investment from the fund. Among the most popular fund investment industries, there are Chemical Engineering, Chemical.
Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in less than 2 investment rounds annually. The important activity for fund was in 2013.
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 0
- Follow on index
- 0.50
- Investments by industry
- Chemical (2)
- Biotechnology (2)
- Chemical Engineering (2)
- Investments by region
-
- United Kingdom (2)
- Peak activity year
- 2013
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 18
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Green Biologics | 21 Jan 2015 | Biotechnology, Chemical, Chemical Engineering | Late Stage Venture | 42M | United Kingdom, England, Vale of White Horse |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.